Association between salivary pH and metabolic syndrome in women: a cross-sectional study

BMC Oral Health

Daniel Gaudet¹  Diane Brisson¹  Monique Tremblay¹ 

[1] Université de Montréal, Department of Medicine, ECOGENE-21 Clinical Research Center; Chicoutimi Hospital, 305 St-Vallier Street, Chicoutimi (Québec), Saguenay, G7H 5 H6, Canada

关键词: Metabolic syndrome;    Cardiometabolic risk;    Salivary pH;   

Others  :  1126368
DOI  :  10.1186/1472-6831-12-40

 received in 2011-12-22, accepted in 2012-08-30,  发布年份 2012

【 摘 要 】

Background

The salivary flow rate is an important determinant of salivary pH. It is influenced by several metabolic syndrome (MetS) components as well as the menopausal status. The cluster of cardiometabolic risk factors that characterizes the MetS could be exacerbated following menopause. The objective of this study was therefore to document the association between salivary pH and MetS expression in women according to the menopausal status.

Methods

In this cross-sectional study, unstimulated saliva collection was performed on 198 Caucasian women of French-Canadian origin of which 55 were premenopausal women (PMW) and 143 menopausal women (MW). Student’s t test, ANOVA and correlation analyses were used to assess the association between salivary pH and MetS components.

Results

The salivary pH level was significantly correlated with several MetS covariates, namely triglycerides (TG), apolipoprotein B (apo B) and plasma glucose concentrations as well as waist circumference and the number of MetS components present in the whole sample and PMW only. Mean pH levels decreased as the number of MetS components increased (p = 0.004). The correlations between salivary pH and variables associated with MetS components tended to be stronger in PMW. The proportion of the variance (R²) of salivary pH explained by MetS-related variables in PMW, MW and the whole sample was 23.6% (p = 0.041), 18.1% and 17.0% (p < 0.001) respectively.

Conclusions

The increasing prevalence of obesity calls for the development of new technologies to more easily monitor health status without increasing the burden of healthcare costs. As such, the salivary pH could be an inexpensive screening tool. These exploratory data suggest that salivary pH may be a significant correlate of the expression of MetS components. However, other studies with different populations are needed to confirm these findings before our observations lead to practical use in clinical settings.

【 授权许可】

   
2012 Tremblay et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
• [2]Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K: Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008, 168(14):1568-1575.
• [3]Carr MC: The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003, 88(6):2404-2411.
• [4]Cameron A: The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas 2010, 65(2):117-121.
• [5]Grundy SM: Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28(4):629-636.
• [6]Chiappin S, Antonelli G, Gatti R, De Palo EF: Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007, 383(1–2):30-40.
• [7]Humphrey SP, Williamson RT: A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001, 85(2):162-169.
• [8]Sreebny LM: Saliva in health and disease: an appraisal and update. Int Dent J 2000, 50(3):140-161.
• [9]Streckfus C, Bigler L, O'Bryan T: Aging and salivary cytokine concentrations as predictors of whole saliva flow rates among women: a preliminary study. Gerontology 2002, 48(5):282-288.
• [10]Lukacs JR, Largaespada LL: Explaining sex differences in dental caries prevalence: saliva, hormones, and "life-history" etiologies. Am J Hum Biol 2006, 18(4):540-555.
• [11]Dodds MW, Dodds AP: Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 83(4):465-470.
• [12]Mata AD, Marques D, Rocha S, Francisco H, Santos C, Mesquita MF, Singh J: Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol Cell Biochem 2004, 261(1–2):137-142.
• [13]Powers PS, Holland P, Miller C, Powers HP: Salivation patterns of obese and normal subjects. Int J Obes 1982, 6(3):267-270.
• [14]Sheikh JS, Sharma M, Kunath A, Fritz DA, Glueck CJ, Hess EV: Reversible parotid enlargement and pseudo-Sjogren's syndrome secondary to hypertriglyceridemia. J Rheumatol 1996, 23(7):1288-1291.
• [15]Streckfus CF: Salivary function and hypertension: a review of the literature and a case report. J Am Dent Assoc 1995, 126(7):1012-1017.
• [16]Streckfus CF, Baur U, Brown LJ, Bacal C, Metter J, Nick T: Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 1998, 44(1):32-39.
• [17]Wardrop RW, Hailes J, Burger H, Reade PC: Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989, 67(5):535-540.
• [18]Lohman TG, Roche AF, Martorell R: Standardization of anthropometric measurements. In The Airlie (VA): 1988; Champaign, IL. Edited by Lohman TRA, Martorel R. Consensus Conference; 1988:39-80.
• [19]Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
• [20]Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, et al.: 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009, 25(10):567-579.
• [21]W.H.O: Definition, diagnosis and classification of diabetes mellitus and its complications. In Report of aWHO Consultation. Geneva; 1999.
• [22]Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34(9):1345-1353.
• [23]McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987, 166(1):1-8.
• [24]Dodds MW, Yeh CK, Johnson DA: Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 2000, 28(5):373-381.
• [25]Forde MD, Koka S, Eckert SE, Carr AB, Wong DT: Systemic assessments utilizing saliva: part 1 general considerations and current assessments. Int J Prosthodont 2006, 19(1):43-52.
• [26]Reynolds SJ, Muwonga J: OraQuick ADVANCE Rapid HIV-1/2 antibody test. Expert Rev Mol Diagn 2004, 4(5):587-591.
• [27]Segal A, Wong DT: Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ 2008, 12(Suppl 1):22-29.
• [28]Qvarnstrom M, Janket SJ, Jones JA, Jethwani K, Nuutinen P, Garcia RI, Baird AE, Van Dyke TE, Meurman JH: Association of salivary lysozyme and C-reactive protein with metabolic syndrome. J Clin Periodontol 2010, 37(9):805-811.
• [29]Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA: Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009, 169(11):1352-1361.
• [30]Polotsky HN, Polotsky AJ: Metabolic implications of menopause. Semin Reprod Med 2010, 28(5):426-434.
• [31]Modeer T, Blomberg CC, Wondimu B, Julihn A, Marcus C: Association Between Obesity, Flow Rate of Whole Saliva, and Dental Caries in Adolescents. Obesity (Silver Spring) 2010, 18(12):2367-2373.
• [32]Nederfors T, Holmstrom G, Paulsson G, Sahlberg D: The relation between xerostomia and hyposalivation in subjects with rheumatoid arthritis or fibromyalgia. Swed Dent J 2002, 26(1):1-7.
• [33]Anttila SS, Knuuttila ML, Sakki TK: Depressive symptoms as an underlying factor of the sensation of dry mouth. Psychosom Med 1998, 60(2):215-218.
• [34]Dormenval V, Budtz-Jorgensen E, Mojon P, Bruyere A, Rapin CH: Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients. Age Ageing 1998, 27(2):123-128.
• [35]Porter SR, Scully C, Hegarty AM: An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 97(1):28-46.
• [36]Goldman JA, Julian EH: Pseudo-Sjogren syndrome with hyperlipoproteinemia. JAMA 1977, 237(15):1582-1584.
• [37]Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T: Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. AJNR Am J Neuroradiol 1997, 18(5):951-958.
• [38]Baum BJ: Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res 1981, 60(7):1292-1296.
• [39]Austin MA: Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 1989, 129(2):249-259.
• [40]Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887.
• [41]Jawed M, Shahid SM, Qader SA, Azhar A: Dental caries in diabetes mellitus: role of salivary flow rate and minerals. J Diabetes Complications 2011, 25(3):183-186.
• [42]Ben-Aryeh H, Cohen M, Kanter Y, Szargel R, Laufer D: Salivary composition in diabetic patients. J Diabet Complications 1988, 2(2):96-99.
• [43]Chavez EM, Borrell LN, Taylor GW, Ship JA: A longitudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91(2):166-173.
• [44]Cherry-Peppers G, Sorkin J, Andres R, Baum BJ, Ship JA: Salivary gland function and glucose metabolic status. J Gerontol 1992, 47(4):M130-M134.
• [45]Marder MZ, Abelson DC, Mandel ID: Salivary alterations in diabetes mellitus. J Periodontol 1975, 46(9):567-569.
• [46]Meurman JH, Collin HL, Niskanen L, Toyry J, Alakuijala P, Keinanen S, Uusitupa M: Saliva in non-insulin-dependent diabetic patients and control subjects: The role of the autonomic nervous system. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 86(1):69-76.
• [47]Ben-Aryeh H, Schiller M, Shasha S, Szargel R, Gutman D: Salivary composition in patients with essential hypertension and the effect of Pindolol. J Oral Med 1981, 36(3):76-78.
• [48]Rahn KH, van Baak M, van Hooff M, Schols M: Studies on salivary flow in borderline hypertension. J Hypertens Suppl 1983, 1(2):77-78.
• [49]Streckfus CF, Wu AJ, Ship JA, Brown LJ: Comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons. Oral Surg Oral Med Oral Pathol 1994, 77(6):615-619.
• [50]Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlof F: Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol 2008, 36(6):523-531.